The Next-Generation Oncology Devices And Solutions Market Is Advancing With Support From Rising Cancer Prevalence Driving Demand For The Market Due To Growing Need For Early Detection And Personalized Care
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Next-Generation Oncology Devices And Solutions Market In 2026 And How Much Will It Reach By 2030?
The market size for next-generation oncology devices and solutions has expanded considerably in recent years. It is anticipated to increase from $16.41 billion in 2025 to $19.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.6%. The historical growth can be attributed to several factors, including the rising global incidence of cancer, the expansion of molecular diagnostic capabilities, the availability of advanced oncology testing tools, the development of hospital-based cancer care programs, and the increasing adoption of targeted therapies.
The next-generation oncology devices and solutions market size is projected to experience significant growth over the coming years. This market is expected to expand to $38.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.4%. The expansion during the forecast period is driven by factors such as the escalating demand for personalized cancer treatment, increasing investments in genomic diagnostics, the proliferation of early screening programs, the growing incorporation of AI in oncology workflows, and advancements in biomarker-based cancer management. Prominent trends anticipated within this period include the rising adoption of precision oncology platforms, increased utilization of NGS-based cancer diagnostics, the expanding integration of digital pathology solutions, the broader application of personalized cancer treatment approaches, and an intensified focus on early detection technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24336&type=smp
Which Drivers Are Advancing The Next-Generation Oncology Devices And Solutions Market Growth?
The rising incidence of cancer is anticipated to propel the expansion of the next-generation oncology devices and solutions market moving forward. Cancer is a condition where abnormal cells multiply uncontrollably and have the potential to spread throughout the body, disrupting normal physiological functions. The escalating prevalence of cancer is largely attributed to aging populations, as the risk of developing the disease increases with age. Next-generation oncology devices and solutions contribute to managing this growing prevalence of cancer by enabling earlier detection, more precise diagnosis, and personalized treatment strategies. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit organization, it is estimated that cancer will be responsible for over 611,000 fatalities in the United States, which is equivalent to more than 1,600 cancer-related deaths daily. Therefore, the increasing prevalence of cancer will be a key driver for the growth of the next-generation oncology devices and solutions market.
How Is The Next-Generation Oncology Devices And Solutions Market Structured Across Different Market Segments?
The next-generation oncology devices and solutions market covered in this report is segmented –
1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
What Trends Are Influencing The Next-Generation Oncology Devices And Solutions Market Outlook?
Leading companies within the next-generation oncology devices and solutions market are intensifying their focus on technological advancements, particularly next-generation sequencing (NGS) target enrichment solutions. This strategic emphasis aims to improve the detection of rare genetic variants, enhance sequencing accuracy, and accelerate decisions in cancer diagnosis and treatment. Next-generation sequencing (NGS) target enrichment solutions are specialized techniques designed to selectively capture and concentrate specific regions of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) for subsequent sequencing, thus enabling a more precise and efficient analysis of genetic variants associated with diseases like cancer. A notable example is Integrated DNA Technologies (IDT), a US-based biotechnology company, which in April 2025, unveiled its xGen Hybridization and Wash v3 Kit. This transformative hybridization capture solution is specifically engineered to accelerate cancer research by streamlining next-generation sequencing (NGS) workflows. The innovative kit significantly reduces hybridization time to just one hour, allowing researchers to complete sample preparation and proceed to sequencing within a single workday. Additionally, by eliminating the need for heated buffers and decreasing hands-on time by 20%, the solution demonstrates high compatibility with automation and is well-suited for high-throughput applications.
Which Key Players Are Active In The Next-Generation Oncology Devices And Solutions Market?
Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.
Access The Complete Next-Generation Oncology Devices And Solutions Market Report:
Which Region Is The Dominant Market In The Next-Generation Oncology Devices And Solutions Market?
North America was the largest region in the next-generation oncology devices and solutions market in 2025. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Next-Generation Oncology Devices And Solutions Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Next-Generation Oncology Devices And Solutions Market 2026, By The Business Research Company
Interventional Oncology Devices Market Report 2026
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
